Gerard J. Criner, MD, FACP, FACCP, discusses the AIRFLOW-3 study which evaluates the efficacy of targeted lung denervation for patients with COPD.
Related Presenters
Gerard Criner, MD, FACP, FACCP
Director, Temple Lung Center
Gerard Criner, MD is an internationally renowned pulmonologist and Temple’s clinical investigator in advanced lung diseases,COPD, pulmonary fibrosis, respiratory failure, and COVID-19. Dr. Criner is a board member for the Global Initiative ...
